BlackRock Japan’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$38K Buy
683
+57
+9% +$3.13K ﹤0.01% 1028
2016
Q3
$35K Sell
626
-80
-11% -$3.92K ﹤0.01% 1030
2016
Q2
$29K Sell
706
-707
-50% -$32.6K ﹤0.01% 1094
2016
Q1
$60K Sell
1,413
-3,444
-71% -$146K ﹤0.01% 994
2015
Q4
$220K Hold
4,857
﹤0.01% 819
2015
Q3
$189K Sell
4,857
-15,207
-76% -$609K ﹤0.01% 794
2015
Q2
$729K Buy
20,064
+16,141
+411% +$511K ﹤0.01% 762
2015
Q1
$113K Buy
3,923
+2,787
+245% +$77.7K ﹤0.01% 945
2014
Q4
$28K Buy
+1,136
New +$25.6K ﹤0.01% 1181

Other funds holding PRAH

BlackRock Japan's PRAH Position: Q4 2016 in Review

BlackRock Japan increased its PRA Health Sciences, Inc. (PRAH) stake by 9.1% in Q4 2016, buying an estimated $3.13K and bringing the position to 683 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

BlackRock Japan first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. The position peaked at $729K in Q2 2015. 188 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

  • BlackRock Japan held 683 shares of PRA Health Sciences, Inc. worth $38K as of Q4 2016.
  • BlackRock Japan bought 57 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $3.13K.
  • PRA Health Sciences, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1028 holding.
  • BlackRock Japan first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
  • BlackRock Japan's PRA Health Sciences, Inc. position peaked at $729K in Q2 2015.
  • 188 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.